Interaction between cd14 and hbv components

摘要

The present invention is based on the finding that CD14 is a receptor for HBV. The invention more particularly describes molecules having HBV receptor activity. The invention also relates to new compounds directed against HBV infections, and methods for identifying them, including in vitro and in vivo model systems to do so. The invention further relates to new vaccine compositions directed against HBV. Additionally the invention also relates to the use of HBV components to treat inflammatory diseases.